Theravance Biopharma Inc (TBPH)
SG&A Expense Growth
-20.00%
Quarterly · Period ending:
TBPH SG&A Expense Growth
Latest reported-20.00%period ending
Latest reported-20.00%period ending
TBPH Quarterly SG&A Growth (QoQ) (0.00% → -20.00%)
Latest values, visible window
High-resolution chart · PNG
TBPH sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -20% | |
| -10.7619% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 4.0302% | |
| -20.9721% | |
| 0.4952% | |
| 14.6486% | |
| 2.7954% | |
| 0.339% | |
| -9.0797% | |
| -17.0757% | |
| 1.0188% | |
| -17.8628% | |
| 0% | |
| -100% | |
| 9.2869% | |
| 10.9806% | |
| -5.8689% | |
| -20.3383% | |
| 28.9751% | |
| 15.2742% | |
| -11.7486% | |
| -1.0645% | |
| 16.2951% | |
| -12.4645% | |
| 1.2265% | |
| -16.3257% | |
| 40.9664% | |
| -13.9488% | |
| 17.0932% | |
| 2.0623% | |
| 0.3944% | |
| 0.1234% | |
| -14.1338% | |
| -1.9448% | |
| 5.336% | |
| 6.0339% | |
| -0.9334% | |
| -0.1102% | |
| 22.9709% | |
| 34.9672% | |
| -31.1463% | |
| 61.6631% | |
| 33.9052% | |
| 2.8515% | |
| 26.0607% | |
| 5.0286% | |
| -0.6609% | |
| 0% |